09 Jun EPR : Regenerative potential – cell-based therapies for heart failure
“Cell-based therapies have the potential to regenerate heart tissue as an alternative to heart transplante. Here, Dr Ibon GARITAONANDIA, Chief Scientific Officer at CellProthera, shares how CD34+ cells are demonstrating promising results in clinical studies.”
europeanpharmaceuticalreview.com | Volume 28 – Issue 02 | April 2023